Philippines patient group funding
PHILIP AGOP PHILIP, M.D., Ph.D., F.R.C.P.
Philadelphia presentation
Phenytoin and Phenytoin Sodium Report on Carcinogens, Thirteenth Edition
Phenylacetate: A Novel Nontoxic Inducer of Tumor Cell
Phenotypes of Pathogenic Mismatch Repair Mutants
Phenotype, distribution, generation, functional and
Phenotype Comparison of MLH1 and MSH2 Mutation Carriers in a
Phenolic acid composition and anticancer activity against human
PHEN1.12.11
PHEN Consensus Statement on PSA Testing for African
PhD-student - MAASTRO clinic
PhD Thesis Danish cancer patients` rehabilitation needs
PhD studentship - Development of preclinical models of High Grade
PhD project proposal template 2012-13
PhD
Phasing of Gene Products during Development1
Phase III Trials of Targeted Anti-cancer Therapies: redesigning the
Phase III trials in oncology: setting standards of care?
PHASE III TRIAL OF TAMOXIFEN ALONE VS
PHASE III TRIAL OF ANTICANCER AGENT LENVIMA® AS FIRST